CN115925795B - 一种高抗氧化活性富硒肽及其制备方法和应用 - Google Patents
一种高抗氧化活性富硒肽及其制备方法和应用 Download PDFInfo
- Publication number
- CN115925795B CN115925795B CN202211382530.8A CN202211382530A CN115925795B CN 115925795 B CN115925795 B CN 115925795B CN 202211382530 A CN202211382530 A CN 202211382530A CN 115925795 B CN115925795 B CN 115925795B
- Authority
- CN
- China
- Prior art keywords
- selenium
- enriched
- peptide
- antioxidant activity
- high antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 99
- 239000011669 selenium Substances 0.000 title claims abstract description 99
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 98
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 55
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 230000003647 oxidation Effects 0.000 claims abstract description 11
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 26
- 235000010469 Glycine max Nutrition 0.000 claims description 25
- 235000019710 soybean protein Nutrition 0.000 claims description 25
- 244000068988 Glycine max Species 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 230000004792 oxidative damage Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 108090000145 Bacillolysin Proteins 0.000 claims description 8
- 108091005658 Basic proteases Proteins 0.000 claims description 8
- 108010004032 Bromelains Proteins 0.000 claims description 8
- 102000035092 Neutral proteases Human genes 0.000 claims description 8
- 108091005507 Neutral proteases Proteins 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- 235000019835 bromelain Nutrition 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 230000003064 anti-oxidating effect Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 4
- 238000013375 chromatographic separation Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 238000003916 acid precipitation Methods 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 241000234671 Ananas Species 0.000 claims 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 230000008642 heat stress Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 41
- 101150116862 KEAP1 gene Proteins 0.000 abstract description 17
- 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 abstract description 15
- 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 abstract description 15
- 230000002209 hydrophobic effect Effects 0.000 abstract description 10
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 9
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 abstract description 8
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 abstract description 8
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 6
- 208000014674 injury Diseases 0.000 abstract description 6
- 125000000539 amino acid group Chemical group 0.000 abstract description 5
- 239000001257 hydrogen Substances 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 210000003855 cell nucleus Anatomy 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229940091258 selenium supplement Drugs 0.000 description 70
- 235000001014 amino acid Nutrition 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000003032 molecular docking Methods 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 102000007079 Peptide Fragments Human genes 0.000 description 7
- 108010033276 Peptide Fragments Proteins 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001742 protein purification Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 208000019061 glycogen storage disease due to GLUT2 deficiency Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 125000003130 L-selenocysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])[Se][H] 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000003277 amino acid sequence analysis Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000011033 desalting Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- JULROCUWKLNBSN-UHFFFAOYSA-N seleno-DL-cystine Natural products OC(=O)C(N)C[Se][Se]CC(N)C(O)=O JULROCUWKLNBSN-UHFFFAOYSA-N 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- -1 NaOH Chemical compound 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000005902 aminomethylation reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000003981 capillary liquid chromatography Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211382530.8A CN115925795B (zh) | 2022-11-07 | 2022-11-07 | 一种高抗氧化活性富硒肽及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211382530.8A CN115925795B (zh) | 2022-11-07 | 2022-11-07 | 一种高抗氧化活性富硒肽及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115925795A CN115925795A (zh) | 2023-04-07 |
CN115925795B true CN115925795B (zh) | 2023-08-11 |
Family
ID=86648038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211382530.8A Active CN115925795B (zh) | 2022-11-07 | 2022-11-07 | 一种高抗氧化活性富硒肽及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115925795B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117024512B (zh) * | 2023-07-07 | 2024-05-14 | 北京工商大学 | 抗焦虑活性肽及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5850016A (en) * | 1996-03-20 | 1998-12-15 | Pioneer Hi-Bred International, Inc. | Alteration of amino acid compositions in seeds |
KR20190036590A (ko) * | 2017-09-28 | 2019-04-05 | 부산대학교 산학협력단 | 생리활성 저분자 펩타이드를 포함하는 콩 추출물을 제조하는 방법 |
CN111996226A (zh) * | 2020-07-31 | 2020-11-27 | 华中农业大学 | 一种大豆7s抗氧化硒肽的制备方法 |
WO2021080928A1 (en) * | 2019-10-20 | 2021-04-29 | Alfredo Flores Galvez | Products and methods using sonication to increase bioactivity of soy peptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7731995B2 (en) * | 2006-09-16 | 2010-06-08 | Alfredo Flores Galvez | Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal |
WO2011060181A1 (en) * | 2009-11-11 | 2011-05-19 | University Of Louisville Research Foundation, Inc. | Lunasin-containing complex and purification of lunasin from plants |
-
2022
- 2022-11-07 CN CN202211382530.8A patent/CN115925795B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5850016A (en) * | 1996-03-20 | 1998-12-15 | Pioneer Hi-Bred International, Inc. | Alteration of amino acid compositions in seeds |
KR20190036590A (ko) * | 2017-09-28 | 2019-04-05 | 부산대학교 산학협력단 | 생리활성 저분자 펩타이드를 포함하는 콩 추출물을 제조하는 방법 |
WO2021080928A1 (en) * | 2019-10-20 | 2021-04-29 | Alfredo Flores Galvez | Products and methods using sonication to increase bioactivity of soy peptides |
CN111996226A (zh) * | 2020-07-31 | 2020-11-27 | 华中农业大学 | 一种大豆7s抗氧化硒肽的制备方法 |
Non-Patent Citations (1)
Title |
---|
Scalable purification and characterization of the anticancer lunasin peptide from soybean;SEBER,L.E.等;POLS ONE.;第7卷(第4期);1-12 * |
Also Published As
Publication number | Publication date |
---|---|
CN115925795A (zh) | 2023-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Purification and identification of antioxidant peptides from duck plasma proteins | |
Samarakoon et al. | Bio-functionalities of proteins derived from marine algae—A review | |
CN115925795B (zh) | 一种高抗氧化活性富硒肽及其制备方法和应用 | |
WO2021004463A1 (zh) | 一种高压辅助酶解制备的花生抗氧化肽及其制备方法 | |
CN104757252B (zh) | 一种具有抗氧化活性的灰树花蛋白酶解物的制备方法 | |
US10548933B2 (en) | Method for preparing broccoli protein peptide mixture | |
WO2016153363A1 (en) | Water-soluble mussel extract | |
Sánchez-Velázquez et al. | Impact of in vitro gastrointestinal digestion on peptide profile and bioactivity of cooked and non-cooked oat protein concentrates | |
CN116514912B (zh) | 抗皮肤氧化损伤的草菇多肽及其应用 | |
CN105777865B (zh) | 具有抗氧化功能的鱼肉耐消化肽、其制备方法和用途 | |
Soto-Sierra et al. | Process development of enzymatically-generated algal protein hydrolysates for specialty food applications | |
Chen et al. | Digestive characteristics and peptide release from wheat embryo proteins in vitro | |
CN112679578B (zh) | 具有抗氧化性和dpp-iv抑制活性的多肽混合物及其制备方法 | |
He et al. | Isolation, identification of antioxidant peptides from earthworm proteins and analysis of the structure–activity relationship of the peptides based on quantum chemical calculations | |
CN109680027A (zh) | 一种灰树花小肽铁螯合物及其制备方法和应用 | |
CN116621934B (zh) | 来源于草菇的抗皮肤氧化和抑制氧化应激的多肽及其应用 | |
CN115746095B (zh) | 一种抗热应激活性富硒肽及其制备方法和应用 | |
CN103740797B (zh) | 一种利用高温花生粕制备高水解度功能性短肽的方法 | |
Ye et al. | Biosynthesis of selenoproteins by Saccharomyces cerevisiae and characterization of its antioxidant activities | |
CN115057916B (zh) | 一种马氏珠母贝肉抗氧化多肽及其制备方法与应用 | |
CN116715724A (zh) | 来源于草菇子实体的抗氧化肽及其应用 | |
CN116731108A (zh) | 草菇抗氧化肽及其应用 | |
CN113388656B (zh) | 一种碎米荠生物活性肽及其应用 | |
CN108976290B (zh) | 一种红毛藻抗氧化肽的制备方法 | |
CN109021072B (zh) | 一种红毛藻抗氧化肽及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230714 Address after: 100000 Room 402, Floor 4, Building 1, Yard 18, Tianrong Street, Zhongguancun Science Park, Daxing District, Beijing Applicant after: BEIJING BEISHIDAN BIOTECHNOLOGY Co.,Ltd. Address before: 33 Fucheng Road, Haidian District, Beijing Applicant before: BEIJING TECHNOLOGY AND BUSINESS University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240422 Address after: Room 404, 4th Floor, Building 1, No. 18 Tianrong Street, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing, 100000 RMB Patentee after: Shengzhi Runze (Beijing) Health Technology Co.,Ltd. Country or region after: China Address before: 100000 Room 402, Floor 4, Building 1, Yard 18, Tianrong Street, Zhongguancun Science Park, Daxing District, Beijing Patentee before: BEIJING BEISHIDAN BIOTECHNOLOGY Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |